Nanoform Finland Plc | Company Release | March 02, 2026 at 16:00:00 EET
Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s CCO Christan Jones’ acceptance of stock options related to the Nanoform press release March 2, 2026, 08.10 EET:
Nanoform Finland plc – Managers' transactions – Jones
____________________________________________
Person subject to the notification requirement
Name: Jones, Christian
Position: Other senior manager
Issuer: Nanoform Finland plc
LEI: 743700JJO2NU8LBS1592
Notification type: INITIAL NOTIFICATION
Reference number: 743700JJO2NU8LBS1592_20260302105251_35
____________________________________________
Transaction date: 2026-02-27
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: Nanoform Finland Oyj stock option 1/2026
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 70337 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 70337 Volume weighted average price: 0.00 EUR
For further information, please contact:
Henri von Haartman
Director of Investor Relations
hvh@nanoform.com
+46 7686 650 11
About Nanoform
Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-clinical to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: DNB Carnegie Investment Bank AB, +46 8 588 685 70, certifiedadviser@dnbcarnegie.se. For more information, please visit www.nanoform.com.